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Outline 
• Background and Significance 
 
• Reasons for Smoking among individuals with co-
morbid substance use (SUD)and/or psychiatric 
disorders (PD) 
 
• Smoking cessation treatment for individuals with co-
morbid substance use (SUD) and/or psychiatric 
disorders (PD) 
 
• Smoking among the Homeless population 
Background and Significance 
 

 Kalman, Morissette and George (2005), Am. J. Addict., 14: 106-123  
• “Nicotine-dependent 
individuals with a 
comorbid psychiatric 
disorder made up 7.1% of 
the population yet 
consumed 34.2% of all 
cigarettes smoked in the 
United States” 
 
 
 
 
Grant, B.F. , Hasin, D.S., Chou, S.P., Stinson, F.S.& Dawson, D.A. (2004). Nicotine dependence and psychiatric 
disorders in the United States: Results from a national epidemiologic survey on alcohol and related conditions. Archives 
of General Psychiatry,61,1107-1115. 
Individuals with SUD and PD are disproportionately 
affected by tobacco caused mortality... 
•In an 11 year retrospective study of 845 individuals who had received 
residential treatment, more than half of all deaths were due to tobacco-
related causes. 
 
•In a 24 year prospective study of heroin users in treatment, death rate of 
smokers x4 (v non-smokers). 
 
•Tobacco and alcohol can act synergistically….heavy users increase cancer 
risk x 37 (v abstainers). 
 
•Individuals with Schizophrenia have elevated rates of respiratory and 
breast cancers and respiratory cancer deaths than individuals without 
schizophrenia 
Hurt RD et al (2006) Mortality following in-patient addictions treatment. JAMA. 
Hser YI et al (1994) Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Preventative Medicine. 
Blot WJ (1992) Alcohol and Cancer. Cancer Research. 
Osborn  et al. (2007). Relative Risk of Cardiovascular and Cancer Mortality in People With Severe Mental Illness From the 
United Kingdom's General Practice Research Database. Arch Gen Psychiatry 
Reasons for Smoking among individuals with 
co-morbid SUD and PD 
 
 
• Psychosocial 
• Genetic • Biologic 
Substance use and smoking 
• Both common and specific addictive factors for alcohol, marijuana, 
cocaine, and habitual smoking transmitted in families 
 
• This specificity suggested independent causative factors for the 
development of each substance dependence.  
Bierut LJ, Dinwiddie SH, Begleiter H, et al. Familial Transmission of Substance Dependence: Alcohol, Marijuana, Cocaine, and Habitual 
Smoking: A Report From the Collaborative Study on the Genetics of Alcoholism. Archives of General Psychiatry 1998; 55:982-988 
• 68% of the association between nicotine and alcohol 
dependence explained by shared genetic effects. 
 
True WR, Xian H, Scherrer JF, et al. Common Genetic Vulnerability for Nicotine and Alcohol Dependence in Men. Archives of General 
Psychiatry 1999; 56:655-661 
Substance use and smoking 
 (8,169 male twins) shared 
genetic disorders further 
predispose to major 
depression and nicotine 
dependence.  
 Kendler KS, Neale MC, MacLean CJ, et al. Smoking and Major Depression: A Causal Analysis. Archives of General Psychiatry 1993; 
50:36-43 
Lyons M, Hitsman B, Xian H, et al. A twin study of smoking, nicotine dependence, and major depression in men. Nicotine & Tobacco 
Research 2008; 10:97 - 108 
(1,566 female twin pairs) average life 
time daily cigarette consumption was 
found to be associated with life time 
prevalence of major depression, 
suggesting that the relationship 
between smoking and major 
depression resulted solely from genes 
which predispose to both conditions. 
Mental health and smoking 
• 63% of the association between post traumatic stress disorder 
and nicotine dependence co-morbidity was explained by 
shared genetic effects. 
Koenen KC, Hitsman B, Lyons MJ, et al. A Twin Registry Study of the Relationship Between Posttraumatic Stress Disorder and Nicotine 
Dependence in Men. Archives of General Psychiatry 2005; 62:1258-1265 
Mental health and smoking 
Mental health and smoking 
• Found a group of candidate genes and individual genes 
among individuals with schizophrenia which were significantly 
linked to smoking behaviors. 
Faraone et al. (2004). A novel permutation testing method implicates sixteen nicotinic acetylcholine receptor genes as risk factors for 
smoking in Schizophrenia families 
Substance use and Smoking 
Ford,Vu, Anthony Drug and 
Alcohol Dependence 2002; 
67:243-248 
 
Marijuana use reduces cessation of tobacco 
smoking in adults 
Barrett,Tichauer, Leyton, et 
al. Drug and Alcohol 
Dependence 2006; 81:197-204 
 
Nicotine increases alcohol self-administration 
in non-dependent male smokers.  
Story & Stark. Journal of 
psychoactive drugs 1991; 
23:203-215 
 
 
increases in methadone dose could increase 
nicotine craving and cigarette consumption for 
opioid-dependent 
Levine et al. Science 
translational medicine 2011; 
3, 107, 107-109  
 
Cigarette smoking can prime the brain to cocaine use 
Mental health and smoking 
Postma et al. 
Psychopharmacology (2006) 
184: 589–599 
 
nicotine reduces sensorimotor gating deficits in 
smokers with schizophrenia 
Barr, Culhane, Jubelt, et al. 
Neuropsychopharmacology 
2007; 33:480-490 
 
 
administration of transdermal patch nicotine 
improves attention and response inhibition in 
nonsmokers with schizophrenia 
Fowler, Volkow, Wang, et al. 
Proceedings of the National 
Academy of Sciences of the 
United States of America 
1996; 93:14065-14069 
 
 
brain levels of monoamine oxidase A (MAO-A) (an 
enzyme associated with depression) were reduced 
in smokers relative to nonsmokers; suggesting that 
people with affective disorders may smoke to 
reduce elevated MAO-A levels in the brain 
McCabe, Chudzik, Antony, 
et al. Journal of Anxiety 
Disorders 2004; 18:7-18 
Smokers with a primary diagnosis of anxiety 
disorder reported greater levels of general anxiety, 
distress, and depression as compared to 
nonsmokers. 
• The use of other substances may foster tobacco use 
 
• Drug treatment facilities may provide an environment 
that supports tobacco use or a factor for delayed 
tobacco use cessation. 
 
• Factors such as neighborhood disadvantage and early 
exposure to substance use may present an ‘exposure 
opportunity’ for subsequent substance use.  
Substance use and Smoking 
Glautier S, Clements K, White JAW, et al. Alcohol and the reward value of cigarette smoking. Behavioural Pharmacology 1996; 7:144-154 
King AC, Epstein AM. Alcohol Dose-Dependent Increases in Smoking Urge in Light Smokers. Alcoholism: Clinical & Experimental Research 
2005; 29:547-552 
Friend KB, Pagano ME. Smoking initiation among nonsmokers during and following treatment for alcohol u se disorders. Journal of Substance 
Abuse Treatment 2004; 26:219-224 
Bobo JK, Husten C. Sociocultural Influences on Smoking and Drinking. Alcohol Research & Health 2000; 24:225-232 
Crum RM, Lillie-Blanton M, Anthony JC. Neighborhood environment and opportunity to use cocaine and other drugs in late childhood and early 
adolescence. Drug and Alcohol Dependence 1996; 43:155-161 
Wagner FA, Anthony JC. Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, 
marijuana, and cocaine. Am. J. Epidemiol. 2002; 155:918-925 
 
• History of tobacco use as a token economy--
cigarettes used as a ‘reward’ for appropriate 
behavior (i.e., smoking privileges) 
 
• Smoking among clients and staff to encourage 
‘socialization’  
 
Mental health and smoking 
Kawachi I, Berkman L. Social ties and mental health. Journal of Urban Health 2001; 78:458-467 
Lawn S. Cigarette smoking in psychiatric settings: occupational health, safety, welfare and legal concerns. Australian and New Zealand 
Journal of Psychiatry 2005; 39:886-891 
Keizer I, Eytan A. Variations in Smoking during Hospitalization in Psychiatric In-Patient Units and Smoking Prevalence in Patients and 
Health-Care Staff. International Journal of Social Psychiatry 2005; 51:317-328 
Morisano D, Bacher I, Audrain-McGovern J, et al. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive 
disorders. Canadian Journal Of Psychiatry. Revue Canadienne De Psychiatrie 2009; 54:356-367 
 
Arguments for Not Providing Tobacco Treatment…. 
“these patients don’t want to quit” 
• 80% of participants in a methadone maintenance program 
and 75% of participants in an alcohol abuse program 
endorsed a desire to quit  
(Richter KP et al., 2001; Ellingstad TP et al, 1999)  
 
 
 
 
• In a review of 9 studies of motivation to quit smoking among 
individuals with psychiatric disorders at least 50% are 
contemplating cessation  
(Siru, Hulse & Tait, 2009).  
“these patients will relapse (to other substances) if 
they try to quit” 
 
• Smoking cessation related to improved quality of life 
 
• Meta-analysis (n = 19 studies) of smoking cessation among 
individuals in addiction treatment and recovery found that 
smoking cessation efforts can ENHANCE rather than 
compromise long-term sobriety  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bobo JK, McIlvain HE, Lando HA, et al. Effect of smoking cessation counseling on recovery from alcoholism: findings from a randomized community 
intervention trial. Addiction 1998; 93:877-887 
McCarthy WJ, Zhou Y, Hser YI, et al. To smoke or not to smoke: Impact on disability, quality of life, and illicit drug use in baseline polydrug users. Journal 
of Addictive Diseases 2002; 21:35-54 
Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addictive Behaviors 2003; 28:1323-1331 
Mc Carthy WJ, Collins C, Hser YI. Does cigarette smoking affect drug abuse treatment? Journal of Drug Issues 2002; 2:61-80 
Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. 
Journal of Consulting and Clinical Psychology 2004; 72:1144-1156 
“these patients are unable to quit” 
• Meta-analysis (n = 19 studies) of smoking cessation among 
individuals in addiction treatment and recovery found increased 
cessation at end of 12 weeks treatment (BUT NO SIGNIFICANT 
EFFECT AT 6 MONTHS!)  
     (Prochaska JJ et al, 2004). 
 
• Recent study found end-of-treatment smoking cessation rates of 
20% among individuals with psychiatric disorders accessing 
outpatient tobacco treatment program 
         (Selby et al, 2010) 
 
• Another recent study found end-of-treatment (between 8 to 26 
weeks) smoking cessation rates of 40% among individuals with 
SUD and/or PD who completed an intensive tailored smoking 
cessation intervention that provided no-cost pharmacotherapy 
combined with behavioural counseling 
         (Khara and Okoli, 2011) 
           
Treating tobacco use in co-morbid 
substance use and psychiatric populations 
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Smoking Cessation by length of stay in the program (n = 678)*  
Barriers to Facilitating tobacco treatment 
Smoking cessation and concurrent substance use 
treatment and recovery 
• Treatment of smoking cessation does not exacerbate the use or 
lead to relapse of another substance- 
o  meta-analysis found summary relative risk was 1.25 (95% CI, 1.07–1.46) 
indicating a significant increase in the likelihood of abstinence from 
substance use among those in smoking cessation treatment as compared 
with the control condition 
• Issues related to concurrent vs. sequential tobacco treatment for 
individuals with alcohol use-  
o study found no difference in the cessation rates at 18 months (12.4% vs. 
13.7%) but prolonged alcohol abstinence for 30 days and 6 months was 
worse in the concurrent group than in the delayed group at 6, 12 and 18 
months.  
Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of 
Consulting and Clinical Psychology 2004; 72:1144-1156 
Joseph AM, Willenbring ML, Nugent SM, et al. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol 
dependence treatment *. Journal of Studies on Alcohol 2004; 65:681(611) 
Role of smoking cessation in mental health services 
• Concerns that smoking cessation will increase psychiatric symptoms 
or relapse among patients.  
o Among individuals with depression, smoking cessation related to increased 
depression symptomatology, which is one of the symptoms of the nicotine 
withdrawal syndrome 
o individuals with anxiety disorders and depression report more severe 
withdrawal symptoms 
o smoking is associated with improvements in prepulse inhibition and sensory 
gating which may be affected by smoking cessation 
• Smoke-free policy and mental health facilities 
o a review of studies examining prohibitions of smoking in psychiatric facilities 
suggests that prohibitions do not have long-term effects on behavioral unrest or 
noncompliance, but neither do they appear to effect smoking cessation 
Patten C, Martin J. Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues. Annals of Behavioral Medicine 1996; 18:190-200 
Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. American Journal of Psychiatry 1992; 
149:464-469 
Adams CE, Stevens KE. Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Frontiers in Bioscience 2007; 12:4755-4772 
Kumari V, Postma P. Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience & Biobehavioral Reviews 2005; 29:1021-1034 
el-Guebaly N, Cathcart J, Currie S, et al. Public health and therapeutic aspects of smoking bans in mental health and addiction settings. Psychiatr Serv 2002; 53:1617-1622 
Ziedonis DMa, Williams JMb. Management of smoking in people with psychiatric disorders. Current Opinion in Psychiatry 2003; 16:305-315 
Costs associated with smoking cessation treatment 
• Even though less expensive than purchasing cigarettes, the cost of 
pharmacotherapy and counseling presents an important barrier to 
seeking treatment 
 
• Such cost barriers to accessing treatment and the potential cost-
effectiveness of treatment have prompted guidelines about 
reducing medication costs (reduced cost or free of charge), 
inclusion of medications as benefits on drug insurance plans, and 
setting up systems for reimbursement for tobacco cessation 
treatment for health care providers. 
Bansal MA, Cummings KM, Hyland A, et al. Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? 
Nicotine & Tobacco Research 2004; 6:303-310 
Reilly P, Murphy L, Alderton D. Challenging the smoking culture within a mental health service supportively. International Journal of Mental Health 
Nursing 2006; 15:272-278 
Fiore M, Jaén C, Baker T, et al. A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update: A U.S. Public Health Service 
Report. American Journal of Preventive Medicine 2008; 35:158-176 
Raw M, McNeill A, West R. Smoking cessation: evidence based recommendations for the healthcare system. British Medical Journal 1999; 318:182-185 
Tobacco Use and Cessation 
in Homeless Populations 
 
 
 
 
 
 
 
Case Example: 
Salvation Army Clinic Tobacco Treatment Program 
 
 
Kentucky Continues to be National 
Leader in Adult Cigarette Smoking 
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Homelessness & Tobacco 
Use 
• Specific data is limited but indicate higher levels of 
cardiovascular and lung disease in homeless or 
recently homeless persons 
• Infectious disease concerns from sharing 
cigarettes/smoking butts on the street 
• Multiple stressors and lack of access to treatment 
contribute to high prevalence of smoking 
Factors contributing to high smoking 
rates in the homeless include: 
 substance abuse 
 lack of shelter and the stress of caring for family and 
children while homeless, lack of private living conditions 
 lack of social support and lack of care from 
society/social empathy 
 low self esteem 
 unemployment 
 lack of education 
 hunger and starvation (smoking has been linked to food 
insecurity due to the appetite suppressing effects of 
nicotine) 
 little or no access to healthcare 
 tobacco use among peers 
Benefits of Quitting for the Homeless: 
• Lower financial strain of smoking 
• Less tobacco related illness for smoker and their 
family (less SHS exposure) 
• Treatment for other substance use is more likely to 
be successful  
• Increased self-efficacy 
• Social normalization 
 
Recommendations of Expert Panel on 
Reducing Tobacco Effects in the 
Homeless: 
• Having all facility staff committed to tobacco 
cessation and decreasing tobacco use among 
their clients 
• Providing access to NRT and a safe and smoke-free 
environment will increase the chances that a client 
can quit tobacco successfully 
• Treatment for nicotine addiction should be 
integrated into a comprehensive approach to 
improving the overall health of clients. 
 
Helping Tobacco Users Quit at the SAC 
• Smoking Cessation Group started in Spring of 2010 with 
a Chest Foundation Grant (Dr. Don Hayes) of $5000 
• Students worked with UK Tobacco Treatment Specialist 
to develop format for the group 
• An open group format, provision of medication 
(primarily NRT, PAP applications for Chantix), quit kits, 
and contingency reward program ($5 gift cards for 
abstinence) was developed 
What’s Working 
• Nicotine replacement has been a critical element 
of the program 
• Structured accountability to the group 
• Reward cards 
• “Café” atmosphere 
• Motivational counseling/goal setting 
• Great student involvement 
• Smooth transition of leadership at end of student 
experience 
Challenges 
• Limited funding 
• Limited funding 
• Limited funding… 
• Transiency of the participants 
• Dedicated meeting space 
• Smoking area 
How We Do What We Do 
Motivational Counseling: 
 Meet the client “where they are” 
 Draw on strengths 
 Work positively to overcome barriers 
 Promote individualized goal setting over specific 
time frame 
 Celebrate successes 
Nicotine Replacement 
• Dose/form tailored to the individual 
• Use patch (21 mg/14 mg/7 mg) and/or gum and/or 
lozenges (2 or 4 mg.) 
• Given out for 1 week duration 
• Use encouraged if smoking > ½ pack/day 
• Dose based on current smoking (each cigarette is 
approx. 2-3 mg. nicotine) 
Oral Medications 
• Chantix not routinely prescribed due to expense 
(approx. $135/month) but is available through PAP if 
sent to clinic 
• Bupropion SR is contraindicated with a history of 
seizures, not available through PAP but is on some 
of Medicaid formularies; can be used with NRT 
• Need to ensure follow up to monitor for side effects 
Student Involvement 
• Opportunity to work on tobacco cessation, the 
leading cause of morbidity and mortality, in a 
challenging setting 
• Develop motivational interviewing skills 
• Fun group to work with! 
Contact information 
Chizimuzo Okoli, PhD, MPH, RN 
Assistant Professor and Director, 
Tobacco Treatment and Prevention Division, Tobacco Policy Research Program,  
University of Kentucky College of Nursing 
315 College of Nursing Building 
Lexington, KY 40536-0232 
Office: 859-323-6606 
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